10:33 AM EDT, 06/25/2024 (MT Newswires) -- Zomedica Pharmaceuticals (ZOM) said Tuesday it secured the CE mark for its point-of-care Truforma Bulk Acoustic Wave diagnostic platform to expand in Europe.

The veterinary diagnostics platform provides quick, accurate results at the point of care in minutes, the company said.

Shares of Zomedica Pharmaceuticals rose 4.1% in recent trading Tuesday.

Price: 0.15, Change: +0.01, Percent Change: +4.10